One platform connecting startups, corporations, research institutions, regions and investors
Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE
1. Technology overview
Medical AI (Medical AI Co., Ltd.) is a Seoul-based company founded in 2019 that develops AI software to read electrocardiograms and score the likelihood of cardiac disease. Its team lists 54 AI researchers and developers and 14 medical staff.
The AiTiA series is AI software as a medical device, including AiTiALVSD for left ventricular systolic dysfunction and AiTiAMI for acute myocardial infarction, while AiTiA ECG Center and ECG Triage support remote reading and HeartSafe handles 1-lead ECG from smartwatches. Customers include health-check networks, hospital groups and public institutions in Korea.
2. Highlighted features & specifications
- AiTiALVSD: Scores left ventricular systolic dysfunction from ECG data.
- AiTiAMI: Screens for acute myocardial infarction from ECG.
- AiTiA ECG Center: Remote consultation platform for sharing ECGs and receiving interpretations.
- AiTiA ECG Triage: Workspace for primary classifiers and secondary interpreters.
- HeartSafe: Gateway software for 1-lead ECG from smartwatches and portable devices.
3. Potential application
Health-check centers in Vietnam can screen executives for low ejection fraction during annual exams. Provincial hospitals can send ECGs to a remote reading center. Insurers can pilot smartwatch ECG screening programs.
4. Benefits
Screens for low ejection fraction and acute MI from a standard ECG without extra imaging.
Remote ECG center and triage tools let one cardiologist team serve many sites.
Works with smartwatch ECG through HeartSafe for lower-cost population screening.
Holds Korean regulatory approvals and, per the company, ISO 27001, HIPAA and GDPR certifications.
5. Market trends & opportunities
Heart failure and MI are often detected late, and AI on routine ECG offers a low-cost screening layer. Smartwatch ECG is expanding the data pool. Vietnamese hospitals and health-check chains with high ECG volumes are potential adopters.
6. Other information
Seoul, Korea; CEO Kwon Jun-myoung. Investors and partners include Naver (2026), KMI health checkup centers and Sejong Hospital group. Approvals include Korea MFDS for AiTiALVSD and AiTiAMI (2023) and a Samsung smartwatch LVSD approval (2025).
